Space Exploration Technologies (SPCX 7.80%) will join the Nasdaq-100 on July 7, after Nasdaq adjusted its rules to provide a "Fast Entry" option for eligible companies. Funds that track the Nasdaq-100, including the Invesco QQQ Trust, will need to buy SpaceX stock after market close on July 6.
JPMorgan estimates that this could drive $4.3 billion in passive inflows into SpaceX. Considering SpaceX has a tiny float -- only about 4% -- that kind of investment may push the price up. Should you buy before then to take advantage?
Image source: Getty Images.
There are a few problems with this strategy. Any boost SpaceX gets will be temporary and unrelated to its long-term value. It could pull back just as quickly, in which case you don't come out ahead unless you take your profits immediately. This is trading, and it's much riskier and far less effective for building wealth than investing.
Also, most investors who follow SpaceX know when it's joining the Nasdaq-100. It's a good bet that plenty of people will buy the stock in anticipation of its index inclusion, which could lead to a much smaller bump than expected, or none at all.
Today's Change
(
-7.80
%) $
-13.32
Current Price
$
157.54
It only makes sense to buy SpaceX if you think it's a good investment. While this space stock has potential, it's extremely risky and volatile. This is a company worth over $2 trillion as of June 30, despite losing $4.9 billion last year. Numbers like that matter much more than inclusion in the Nasdaq-100, and they're one of the reasons you may be better off waiting to invest in SpaceX.
JPMorgan Chase is an advertising partner of Motley Fool Money. Lyle Daly has positions in Invesco QQQ Trust. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy.
Apple (AAPL, Financials) is facing new pressure in Russia after the country's antitrust regulator accused the company of discriminating against local search eng
Apple’s Hide My Email feature is a convenient privacy tool that uses disposable addresses to hide a user’s true email for the sake of online anonymity. Unfortunately, new research appears to show that a bug in the feature allows users’ real email addresses to be unmasked.
The bug was reported by 404 Media, which says that it has tested and verified that the vulnerability exists. Tyler Murphy, the researcher who found the bug, said that he warned Apple about the problem over a year ago and that it was unclear why the company had yet to remedy the problem. All of the attempts to exploit the bug have been successful, Murphy added.
“We don’t know the full scope of the issue, but in our limited tests with volunteers, 100% of Hide My Email addresses were exploitable,” Murphy told the outlet. Details of the vulnerability haven’t been publicly disclosed, for fear that it will be exploited.
Murphy is the co-founder of EasyOptOuts, which offers a paid data-removal service that takes your information off of data broker sites. He told 404 Media that “publicly accessible people-search sites make it easy to link an email address to other personal details, so people relying on Hide My Email for safety may be at risk.”
TechCrunch reached out to Apple for more information and will update this story if it responds.
When it comes to the tech world, privacy tools are hard to come by and, unfortunately, even when they do exist, they don’t always work. Apple has been accused of this sort of thing before.
Case in point: The company was sued in 2022 after it was reported that iPhone apps continued to send analytics data to Apple even when the iPhone Analytics privacy setting was turned on.
Similarly, in 2023, researchers found another one of Apple’s privacy features to be effectively “useless.” The research claimed that a tool that was supposed to anonymize mobile users’ Wi-Fi connections by providing randomized MAC addresses (an easily trackable identifier) was simply exposing the user’s real MAC address.
Apple has built a large part of its reputation and branding on user privacy, so hopefully it manages to address the apparent Hide My Email bug with some expedience. If it can learn to better stand behind its privacy promises, that wouldn’t be the worst thing in the world either.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Lucas is a senior writer at TechCrunch, where he covers artificial intelligence, consumer tech, and startups. He previously covered AI and cybersecurity at Gizmodo. You can contact Lucas by emailing [email protected].
Key Takeaways Meta shares rallied Wednesday following a report that the company is considering launching a business to sell excess compute capacity.The move could put Meta in competition with cloud services from Microsoft, Alphabet, and Amazon. Get personalized, AI-powered answers built on 27+ years of trusted expertise.
Meta's stock is soaring on signs it could be on the verge of launching a new business.
Meta Platforms (META) shares were up 10% recently, making it one of the best-performing stocks in the S&P 500 Wednesday, following a report that it aims to launch a cloud computing business. Meta has created an internal initiative called "Meta Compute" to manage the massive amounts of compute the company is acquiring, and is considering selling excess capacity, according to a Bloomberg report.1
The social media giant is also considering building a business selling access to AI models from several companies hosted through its existing AI infrastructure, akin to Amazon Web Services' offerings through the Bedrock platform, Bloomberg reported. Meta declined to comment on the report.
Such an operation could bring the Facebook and Instagram parent in competition with cloud services from Alphabet's (GOOGL) Google Cloud, Microsoft's (MSFT) Azure, and Amazon's (AMZN) AWS.
Why This Matters to Investors The move could also help Meta soothe concerns about its massive spending plans to build out its AI infrastructure.
Meta CEO Mark Zuckerberg said at Meta's annual investor day back in May that "almost every week" Meta's partners ask them about a business to sell compute or model access. At the time, he said Meta had not yet pursued selling its compute because the company expected to have a use for all of it, but said it could be an option if Meta gets to "a point where we feel that we have overbuilt," per an AlphaSense transcript.
Shares of so-called "neocloud" companies CoreWeave (CRWV) and Nebius Group (NBIS) tumbled to lead decliners in the Nasdaq 100 following the news, dropping about 11% and 14%, respectively.
Even with Wednesday's rally, Meta shares are down about 6% year-to-date, after a slump amid concerns about its AI progress and the scale of its investments.
Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) shares rose nearly 10% to $619.44 after a report that the company is building a cloud business to sell its excess AI computing capacity.
Bloomberg News, citing people familiar with the matter, said the move could reduce Meta's reliance on advertising and set it against the three firms that dominate cloud infrastructure. For a company that still draws almost all its revenue from ads, that would mark a significant widening of the base.
What Meta is weighing
One option under review is letting customers tap AI models hosted on Meta's own infrastructure. That would resemble Amazon Web Services' Bedrock platform, which sells access to a menu of models on a pay-as-you-go basis.
The idea is not new inside the company. Zuckerberg flagged it at Meta's annual shareholder meeting in May, saying it was "definitely on the table." He said other companies approach Meta almost every week asking to buy access to its models or spare capacity at a premium.
Selling that access would become a live option, he added, if Meta reached a point where it had overbuilt its data-centre capacity.
A hedge against overbuilding
That framing matters. It positions a cloud business less as a bold pivot than as a use for capacity Meta may otherwise leave idle. The company is pouring money into data centres, and a resale market would let it recoup some of that outlay rather than strand it.
The spending numbers behind the strategy are large. Big Tech firms are expected to spend more than $700 billion on AI infrastructure this year, up from around $400 billion in 2025. At that scale, even a modest overbuild leaves a lot of expensive silicon looking for work.
Taking on the incumbents
The move would push Meta into a contest with Amazon, Microsoft and Alphabet, the three companies that have spent a decade building the cloud market. None will cede ground easily, and Meta would arrive as a challenger rather than an equal.
The prize is a revenue stream that does not rise and fall with the advertising cycle. That is the real draw. Meta's ad business is vast but exposed to economic swings and platform shifts, and a cloud arm would give it something steadier to lean on.
Meta shares jumped nearly 10% Wednesday following a report the company is planning to sell excess computing power, allowing it to recover some of the billions of dollars it has sunk into AI.
The Menlo Park, Calif.-based tech giant, which has rushed to secure pricey data centers and chips, is building a new cloud business to sell access to its AI models and compute, according to Bloomberg.
It’s welcome news for investors, who have grown anxious over whether Meta will be able to deliver returns on the hundreds of billions of dollars it has spent to build up a trove of coveted computing power, with a goal of developing “superintelligence.”
Meta CEO Mark Zuckerberg has insisted that it’s crucial for Meta to build up as much computing capacity as possible. AP Photo/Alex Brandon Meta declined to comment.
The new cloud business would allow Meta to generate revenue on any leftover capacity, while setting it up to compete with industry leaders like Amazon, Microsoft, Google, CoreWeave and SpaceX.
Meta is debating whether the cloud business should be structured to sell access to its own AI models, or to raw computing power itself, according to the report, which noted that plans could change.
If it decides to sell access to AI models on its own infrastructure, it would be taking a similar approach to Amazon – running the data centers and chips that power the bots and then charging customers fees to access them.
Elon Musk’s SpaceX – which took over his artificial intelligence firm xAI in February – has adopted a similar approach, striking lucrative rental deals with Anthropic and Google for access to its huge Memphis data center.
Anthropic agreed to pay $1.25 billion a month, while Google signed off on a $920 million monthly fee.
Meta could alternatively choose to sell access to its computing capacity, similar to CoreWeave’s business model.
The Menlo Park, Calif.-based tech giant is reportedly building a new cloud business to sell access to its AI compute. Anadolu via Getty Images OpenAI kicked off the race to amass large amounts of computing capacity in 2022 with the launch of its ChatGPT bot, as developers recognized that there was a limited amount of power despite skyrocketing demand.
In April, shares in Meta slid after the company raised its spending forecast to $145 billion amid mounting fears that AI stocks are overvalued, similar to the “dot-com bubble” of the early 2000s.
Meta CEO Mark Zuckerberg has repeatedly insisted that it’s crucial for the company to build up as much computing capacity as possible and consider its use later, since supply is limited – but in May, he signaled an openness to selling excess power.
“It’s definitely on the table,” Zuckerberg said at the annual shareholder meeting. “Almost every week there are different companies that come to us from the outside asking us to both stand up an API service or asking if we have compute that they could buy from us at some premium to what we’ve bought it at.”
The new cloud business would allow Meta to generate revenue on any leftover capacity. Hans Lucas/AFP via Getty Images “We haven’t done that yet because we think we have a use for the compute,” he added. “But obviously if we get to a point where we feel that we have overbuilt, then that is an option that we have, and that is partially what gives us confidence in investing in building this out.”
Last summer, Meta paid a whopping $15 billion to hire AI brainiac Alexandr Wang and take a 49% stake in his startup, Scale AI.
The company released its first AI model under Wang’s lead in April – though the model, called “Muse Spark,” did not live up to hopes for a state-of-the-art bot.
Wang has defended the model, saying it should serve as an “appetizer” while Meta is “cooking” up the main course.
WhatsApp recently began offering usernames, designed to help people connect while keeping their phone numbers private.
Now, the Meta-owned company said it will allow high-profile names to be claimed only by legitimate owners as it tries to prevent impersonation on the messaging platform, Bloomberg News reported Wednesday (July 1).
The username feature was introduced Monday (June 29), when Meta began letting customers reserve a unique handle for launch later in the year.
“Usernames are our latest step to make WhatsApp even more private. There’s no directory to browse and no suggestions—people will need to know your exact username to contact you for the first time,” the company wrote in its announcement.
According to the Bloomberg report, the move is facing scrutiny from India’s government, which is expected to call on WhatApp to explain the implications of the feature. Meta told Bloomberg it has built several layers of protection against scams into WhatsApp’s usernames offering.
“Other users need to know the exact username to message you, we will limit how many new people an account can contact, block repeated attempts to guess someone’s username key, and have systems to detect and remove activity showing common impersonation and abuse patterns,” the company said.
Bloomberg noted that India represents the largest market for WhatsApp with upwards of 600 million users, meaning any serious government pushback can hinder the global rollout of the username feature.
This is happening at a time when scammers are increasingly using social media channels to target their victims. Findings by the Federal Trade Commission (FTC) released in April showed that nearly 30% of people who reported losing money in a scam last year say that the scam began on social media.
“Scammers may hack a user’s account, exploit what a user posts to figure out how to target them, or buy ads and use the same tools used by real businesses to target people by age, interests or shopping habits,” the commission said.
The FTC’s data are in line with PYMNTS Intelligence research which showed that digital communication channels are among the most common ways cybercriminals make their first contact with financial scams victims.
Meta introduced a series of artificial intelligence-powered anti-scam tools for WhatsApp, Facebook and Messenger earlier this year.
In the case of WhatApp, that meant a warning system that alerts users of potentially suspicious device-linking requests, aimed at preventing scams where fraudsters try to dupe WhatsApp users into connecting their account to another device.
Shares of Meta Platforms jumped more than 6% on Wall Street on Wednesday after a report said the social media giant is preparing to launch a cloud computing business that would sell AI computing power to outside customers.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Katie Greifeld, Bailey Lipschultz, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
Meta shares popped on reports of a new cloud-computing venture, but some analysts wonder if that would signal disappointing uptake of internal AI offerings.
Microsoft (MSFT +2.95%) stock moved higher in Wednesday's trading as investors shifted their positioning when it came to artificial intelligence stocks. The company's share price closed out the day up 3%. Meanwhile, the S&P 500 fell 0.2%, and the Nasdaq Composite moved 0.7% lower.
Investors moved out of AI chip stocks today and bought back into artificial intelligence software plays. In addition to that positive catalyst, Microsoft also scored a new long-term deal.
Image source: Getty Images.
Microsoft is seeing bullish momentum as AI software regains favor While AI chip stocks have enjoyed very strong bullish momentum this year, many leading artificial intelligence software providers have had a rougher go of things. It's possible that the dynamic is in the early stages of shifting.
It's still too early to proclaim that a sustained rotation back into AI software stocks is underway, but trading over the last week has seen top chip stocks give up some ground and investment capital flow into leading software names. Even with the benefit of some recent bullish momentum, Microsoft stock is still down roughly 20.5% year to date -- and sustained recovery for the broader software space could power more big gains for the stock.
Today's Change
(
2.95
%) $
11.01
Current Price
$
384.03
Microsoft just landed another big long-term deal Haleon announced today that it had entered into a new partnership with Microsoft to expand AI and analytics capabilities across its business. The five-year deal sees Haleon expanding its integration of Microsoft 365 Copilot and other tools. Microsoft stock has seen some pullbacks this year due to concerns about Copilot's competitive positioning compared to rival offerings from Anthropic, OpenAI, and other AI leaders, but the company has been landing deals for the service recently that reinforce how strong its position remains in the enterprise software market.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft. The Motley Fool recommends Haleon Plc. The Motley Fool has a disclosure policy.
The payment resolves allegations that Alibaba Group and AUS Merchant Services allowed merchants to sell and import illegal pharmaceuticals and other restricted items into the U.S.
NEW YORK--(BUSINESS WIRE)--Citibank, N.A. is announcing the redemption, in whole, constituting $1,500,000,000 of its 4.929% Notes due 2026 (the “fixed rate notes”) (ISIN: US17325FBJ66) and $1,000,000,000 of its Floating Rate Notes due 2026 (the “floating rate notes” and together with the fixed rate notes, the “notes”) (ISIN: US17325FBH01). The redemption date for the notes is July 6, 2026 (the “redemption date”). The cash redemption price for the notes payable on the redemption date will equal.
Key Takeaways NKE is benefiting from resilient international demand, led by EMEA and performance-focused categories. NIKE continues to face pressure in Greater China as it restructures inventory and its marketplace.NKE is strengthening growth via localized products, digital initiatives and improving North America trends. NIKE, Inc. (NKE - Free Report) reported fourth-quarter fiscal 2026 results, wherein earnings per share (EPS) and revenues beat the Zacks Consensus Estimate. The company’s EPS of 20 cents increased 42.9% from the year-ago level and beat the Zacks Consensus Estimate of 11 cents.
Revenues of the Swoosh brand owner dipped 1% year over year to $10.97 billion but surpassed the Zacks Consensus Estimate of $10.85 billion. The upside was aided by wholesale growth and increased revenues in North America.
This Zacks Rank #4 (Sell) company’s shares have lost 7.1% in the past three months compared with the industry’s 1.8% drop.
NKE’s Revenue Picture for Q4NIKE’s fourth-quarter revenues fell 4% on a currency-neutral basis. Revenues for the NIKE Brand were $10.72 billion, flat on a reported basis and down 3% on a currency-neutral basis. The weakness was mainly due to declines in Greater China and EMEA, somewhat offset by growth in North America.
Wholesale revenues increased 4% on a reported basis and 1% on a currency-neutral basis to $6.6 billion. Growth was mainly driven by North America, partly offset by lower revenues in Greater China.
NIKE Direct revenues declined 7% on a reported basis and 9% on a currency-neutral basis to $4.1 billion. The drop was due to a 12% decline in NIKE Brand Digital and a 7% fall in NIKE-owned stores.
NIKE’s Segment Trends Stay MixedNorth America revenues rose 3% year over year to $4.83 billion. Footwear increased 4% to $3.23 billion, apparel rose 1% to $1.31 billion and equipment slipped 1% to $292 million.
EMEA revenues fell 1% on a reported basis and 6% on a currency-neutral basis to $2.98 billion. Footwear declined 4% to $1.82 billion, while apparel rose 6% to $982 million and equipment dropped 3% to $172 million.
Greater China remained under pressure, with revenues down 12% on a reported basis and 17% on a currency-neutral basis to $1.30 billion. Footwear fell 13% to $938 million, apparel declined 10% to $334 million and equipment dropped 17% to $25 million.
APLA revenues increased 1% on a reported basis but were down 1% on a currency-neutral basis to $1.60 billion. Footwear remained flat at $1.1 billion, apparel rose 6% to $420 million and equipment dipped 2% to $62 million.
Converse revenues dropped 32% on a reported basis and 34% on a currency-neutral basis to $244 million due to decreases in all territories.
NKE’s Costs and MarginsGross profit rose 21% year over year to $5.39 billion. The gross margin expanded 890 basis points (bps) to 49.2%, primarily due to a 900-bps benefit with respect to the recovery of IEEPA tariffs. Excluding this benefit, management said the gross margin would have been 40.2%, down 10 bps year over year.
Selling and administrative expenses fell 2% year over year to $4.08 billion. As a percentage of sales, SG&A expenses were 37.2%, down 20 bps from 37.4% in the year-ago quarter.
Demand creation expenses dipped 4% to $1.20 billion, mainly due to lower brand marketing expenses. Operating overhead expenses fell 1% to $2.88 billion, aided by a decline in other administrative costs.
NIKE’s Financial PositionNIKE ended fiscal 2026 with cash and equivalents of $7.56 billion, up 1% year over year. Short-term investments were $1.46 billion, down 13% from the year-ago period. As of May 31, 2026, the company had long-term debt (excluding current maturities) of $5.94 billion and shareholders’ equity of $14.87 billion.
Inventories were $7.50 billion at the end of fiscal 2026, flat year over year. In fiscal 2026, the company returned nearly $2.5 billion to shareholders through dividends and share repurchases. It paid $2.4 billion in dividends, representing a 5% increase from the prior year. Additionally, the company repurchased 1.8 million shares for $123 million under its four-year, $18 billion share repurchase program.
NKE’s Outlook and Key PrioritiesManagement said the operating environment remains volatile, citing evolving tariff policies, Middle East disruption, oil prices, operating costs, consumer behavior and weaker store traffic and retail sales.
For the first quarter of fiscal 2027, NIKE expects reported revenues to decline in the low to mid-single digits, with Q2 having a sequential deceleration from Q1. It expects gross margin expansion earlier beginning in the fiscal first quarter. The company expects no foreign exchange benefit, with currency-neutral revenue trends consistent with recent performance.
The gross margin is expected to be slightly positive in the first quarter. The forecast assumes incremental tariff rates of 10% through the end of July and 15% thereafter. SG&A dollars are expected to be flat in the fiscal first quarter. Operating overhead is expected to decline, while demand creation is likely to grow in high single digits as the company invests in the World Cup. It is taking actions to control improving EBIT margins and increasing cash flow from operations.
Key Picks in the Consumer Discretionary SpaceColumbia Sportswear Company (COLM - Free Report) , which engages in the sourcing, marketing and distribution of outdoor and active lifestyle apparel, footwear, accessories and equipment, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
COLM delivered a trailing four-quarter earnings surprise of 44.1%, on average. The Zacks Consensus Estimate for Columbia Sportswear’s current financial-year sales indicates growth of 2.6% from the year-ago number.
Duluth Holdings Inc. (DLTH - Free Report) , which deals in casual wear, workwear and accessories for men and women, currently sports a Zacks Rank of 1.
Duluth Holdings delivered a trailing four-quarter earnings surprise of 107.5%, on average. The Zacks Consensus Estimate for DLTH’s current financial-year EPS indicates a rise of 39.5% from the year-ago number.
Ralph Lauren Corporation (RL - Free Report) , which is a leading major designer, marketer and distributor of premium lifestyle products, currently carries a Zacks Rank #2 (Buy). RL delivered a trailing four-quarter earnings surprise of 9.1%, on average.
The Zacks Consensus Estimate for Ralph Lauren’s current financial-year EPS indicates a rise of 10.5% from the year-ago number.
NIKE (NKE +5.05%), a global athletic footwear and apparel designer, marketer, and seller, closed at $43.14, up 5.09%. The stock rose after premarket results beat estimates, though investors are watching tariff-related profit support and a cautious revenue outlook. Trading volume reached 74.5M shares, coming in about 181% above its three-month average of 26.5M shares.
How the markets moved todayS&P 500 (^GSPC 0.22%) closed at 7,485, down 0.19%, while the Nasdaq Composite (^IXIC 0.66%) finished at 26,040, down 0.66%. Among footwear and apparel retail, focused on athletic and sportswear products peers, Adidas closed at $102.83, up 0.25%, and Under Armour closed at $6.59, up 3.13%, as investors weighed brand demand and a 2026 FIFA World Cup backdrop.
What this means for investorsWhile Nike’s revenue dipped 1% and the company delivered an otherwise mixed earnings report, the stock rose higher today. I think this reaction has more to do with Nike’s stock being down 73% over the last five years than anything incredible highlighted in Q4.
That said, Nike running shoes grew sales by double digits for five straight quarters, the company’s wholesale operations in North America also grew by double digits, and inventory remained flat. Said another way, Nike’s “core” is improving.
However, sales in China dropped 17%, underscoring the country’s ongoing weakness. Meanwhile, Converse sales also dropped by 32%, adding to the company’s struggles.
With management guiding for a low-to-mid single-digit sales decline in the first half of fiscal 2027, I’d rather just wait and see with Nike stock, rather than try to time the bottom perfectly. This has been a multi-year “turnaround,” and I’d rather see some tangible improvement before considering an investment at this point, despite the company showing a few signs of progress in Q4.
I keep hitting the buy button on NVIDIA (NASDAQ:NVDA | NVDA Price Prediction), and the pullback to $200.09 has only made me more aggressive. This is the position I add to every time the tape gives me a discount, because the business behind the ticker is compounding faster than the multiple is expanding. When institutions rotate on a yield curve flattening from 0.74% to 0.30%, I see a gift. That is the entire confession.
The core thesis is simple. Jensen Huang runs the only company that sells the picks and shovels for what he calls “the buildout of AI factories, the largest infrastructure expansion in human history”. Every frontier lab, every hyperscaler, and every sovereign AI project routes through CUDA, NVLink, and Blackwell. I am paying for a toll booth.
Reason one is the operational reality. Q1 FY2027 revenue landed at $81.615 billion, up 85.23% year over year, with Data Center at $75.246 billion (92% YoY growth) and networking at $14.8 billion (199% YoY growth). Non-GAAP EPS of $1.87 marked the fourth consecutive quarterly beat. Gross margin sits at 75.0% at this scale. Free cash flow reached $48.554 billion in a single quarter. Growth is accelerating.
Reason two is the valuation the market is handing me. Forward earnings sit at roughly 22x, with a trailing PE near 30x and a PEG of 0.593. For a business posting a 63% profit margin and 114.3% return on equity, that multiple is a compressed price for the highest quality earnings stream in technology. Analyst consensus target sits at $301.62 against my $200.09 cost basis today.
Reason three is capital return that finally shows up on my brokerage statement. Management raised the dividend from $0.01 to $0.25 per share, authorized an additional $80.0 billion in buybacks, and returned roughly $20.0 billion to shareholders in Q1 alone. Supply commitments climbed to $119.0 billion, telling me the order book behind the guidance is real.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Now the risk I refuse to ignore. China is the real headwind. Q2 FY27 guidance of $91.0 billion explicitly excludes Data Center compute revenue from China, and Q1 shipped no H20 products to China versus $4.6 billion in the year-ago quarter. If restrictions harden further, a growth vector closes. The reason my thesis holds: NVIDIA is already growing revenue 85% year over year with that China lane essentially at zero. The rest of the world is buying every wafer Taiwan Semi can allocate, and executives told analysts they are sold out on Blackwell demand.
The one-month drawdown of 5.13% gave me a lower cost basis on a business that has compounded revenue from $46.743 billion to $81.615 billion in four quarters. Retail sentiment on Reddit already recovered from a capitulation floor at 22 on June 21 back to 67 on June 30. My conviction never left.
I keep buying because Vera Rubin follows Blackwell, agentic AI is scaling into every industry, and the toll booth is still the toll booth. The buy button stays green as long as that math holds.
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Walmart stock is taking a hit today. What’s weighing on WMT shares? What The Note SaysThe note making the rounds indicates that Walmart’s U.S. comparable sales appear to have decelerated to some degree, raising questions about whether the company can meet current consensus expectations. The outcome, per the note, hinges in large part on how sales trends develop through the rest of the month.
The note also flags that Walmart appears to be actively working to bring down inventory levels through price reductions, and that the company is leaning on tariff refunds to help absorb the cost of those markdowns.
Walmart Stock: Key Levels and Momentum AnalysisMomentum is the more important factor right now. RSI is at 24.96, placing the stock in oversold territory and signaling that recent selling has stretched beyond typical ranges. RSI tracks how extended a move is compared with recent price action, and readings this low often appear near short‑term bounce attempts, although they do not guarantee a lasting bottom.
From a level‑based trading perspective, the chart is now defined by a wide range between support near a major round‑number floor and resistance near the prior consolidation zone. May produced the latest swing high and the 52‑week high, while June set the most recent swing low. This pattern helps explain why traders are treating the current decline as more than a routine pullback.
Key Resistance: $123.00 — A round‑number level that also sits near the 50‑day simple moving average zone where rebounds often stall. Key Support: $100.00 — A major round‑number floor that sits above the 52‑week low area and can act as a key reference point for dip buyers. Walmart Benzinga Edge Rankings ExplainedBelow is the Benzinga Edge scorecard for Walmart, showing how the company stacks up against the broader market:
The Verdict: Walmart’s Benzinga Edge profile shows a mix of strong quality and strong growth with only moderate momentum. This fits a stock that is fundamentally stable but technically under pressure. Long‑term investors may focus on whether momentum improves near support, while traders will watch to see if any rebound can retake the $123.00 zone.
WMT Shares Are DippingWMT Price Action: Walmart shares were down 4.35% at $108.33 at the time of publication on Wednesday, according to Benzinga Pro.
Image: Tada Images/Shutterstock
Market News and Data brought to you by Benzinga APIs
JPMorgan Chase (NYSE:JPM | JPM Price Prediction) posted a fortress quarter as passive flows shovel capital into the iShares Russell 2000 ETF (NYSEARCA:IWM). JPM printed record markets revenue while the Russell reconstitution funneled $334 billion of mechanical buying into 2,000 small-cap names. Stacking the bank’s pristine balance sheet against a basket of floating-rate borrowers shows where defensive power sits right now.
Fortress Earnings Meet a Reconstitution Sugar Rush JPM’s Q1 numbers were strong. Revenue hit $49.84 billion, net income reached $16.49 billion, and EPS landed at $5.94. The Commercial & Investment Bank drove the story, with revenue up 19% to $23.38 billion and record $11.60 billion in Markets revenue. Advisory fees jumped 82%, signaling deal pipelines are unfreezing.
IWM’s story is mechanical. The small-cap benchmark rallied 21.8% year to date and 39.19% over the past year. Much of June’s pop came from reconstitution inflows rather than earnings strength.
Driver JPM IWM (Russell 2000) Revenue engine Markets, IB advisory, payments Cyclical small-caps, regional banks Balance sheet $1.5 trillion in cash and securities Heavy floating-rate debt exposure Capital return $8.10 billion in Q1 buybacks Passive index reweighting flows Self-Funding Giant vs. Floating-Rate Hostages Jamie Dimon entered this quarter with $291 billion in CET1 capital and $572 billion in total loss-absorbing capacity. Provisions for credit losses dropped 24% year over year to $2.51 billion, pointing to improving credit conditions. Dimon flagged “an increasingly complex set of risks”, then kept the buyback machine running.
The small-cap basket lives on the other side. The Fed funds rate has held at 3.75% for roughly six months, and the 10-year Treasury yield sits at 4.40%. The 2s/10s curve has compressed to 0.31%, a percentile rank of 1.6 over the past year. Russell-heavy cyclicals feel that math first. Transportation sector profits dropped 16.4% from the 2024Q4 baseline.
The Next Test Is Whether Small-Cap Margins Survive the Pause Keep an eye on JPM’s Q2 release. Polymarket traders price 97.4% odds that investment banking fees clear $2.55 billion, with confidence fading above $3.0 billion at 42.5%. One yellow flag: noninterest expense ran 14% higher year over year, outpacing revenue growth. For IWM, the question is whether reconstitution flows can mask weakening earnings power in the smallest, most rate-sensitive names.
Why I Lean Toward JPM Over the Russell Basket Today Given a choice between owning JPM at $329.05 or chasing the IWM rally, I take the bank. JPM has gained 9.95% over the past month yet only 3.1% year to date, leaving room to work. Earnings power, the buyback cadence, and the credit trend all line up. The Russell basket has already done heavy lifting this year, with much sourced from index mechanics. For turnaround investors betting on a Fed pivot, IWM offers higher upside variance. The cleaner setup is the bank that compounds when capital costs stay elevated.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and JPMorgan Chase didn't make the cut. Grab the names FREE today.
Ford Motor Company (F 1.87%) is down nearly 20% from its late-May peak. A weak sales report, uncertainty around tariffs, and another recall largely triggered the pullback. The news wasn't great, but Ford has an unrelated catalyst investors should pay attention to.
Today's Change
(
-1.87
%) $
-0.26
Current Price
$
13.64
Ford Energy, the company's newest endeavor, marks a shift away from a sluggish electric-vehicle segment toward battery energy storage systems (BESS) for utilities, data centers, and large industrial and commercial customers in the U.S. Ford Energy plans to deploy at least 20 gigawatts annually, beginning in late 2027.
Even with Ford Energy's promising outlook, the automaker is still facing substantial headwinds. The EV division will likely post approximately $4 billion in losses this year. As competition increases, the recalls and macroeconomic picture in the U.S. don't make things any easier for the brand.
Image source: Getty Images.
Ford's stock is relatively inexpensive. Its forward P/E ratio is currently less than 10, and with a $0.60 annual dividend, the 4.25% yield is attractive. Ford's longer-term success will be determined by how well its energy division performs.
The demand is there. The BESS market is expected to exceed $160 billion annually by 2034, growing at a nearly 19% CAGR. Ford needs Ford Energy to offset the losses from EVs. If it can achieve that goal, I'd expect patient investors to be rewarded. Still, revenue from Ford Energy won't have a significant impact for at least another year, so patience is required.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
NEW YORK--(BUSINESS WIRE)--The U.S. Treasury today announced that two BlackRock iShares exchange traded funds (ETFs) will be offered among the investment options available under Trump Accounts, a federal initiative designed to enable a generation of American children to begin building wealth from birth. “BlackRock is proud to support Trump Accounts. For generations, U.S. capital markets have been a powerful engine of growth and wealth creation,” said Larry Fink, Chairman and Chief Executive Off.
SEATTLE--(BUSINESS WIRE)--Starbucks Corporation (NASDAQ: SBUX) today announced that its Board of Directors has approved a quarterly cash dividend of $0.62 per share of outstanding Common Stock. The dividend will be payable in cash on August 28, 2026, to shareholders of record on August 14, 2026. About Starbucks Since 1971, Starbucks Coffee Company has been committed to responsibly sourcing and roasting high-quality arabica coffee. Today, with a global footprint of more than 41,000 company-opera.
"To be successful as a CMO today, you've got to keep it simple," said Mark Kirkham, CMO of PepsiCo, in an interview at the 2026 Cannes Lions.
Kirkham cited the over 50-year-old "Pepsi Challenge" as an example of a straightforward, creative idea that hasn't lost its potency. "It's essentially a sampling activation," Kirkham said. "Sampling is a powerful, simple tool to put can-in-hand and brand-in-hand, and get people to try your product in a different way."
"To be successful as a CMO today, you've got to keep it simple," said Mark Kirkham, CMO of PepsiCo, in an interview at the 2026 Cannes Lions.
Kirkham cited the over 50-year-old "Pepsi Challenge" as an example of a straightforward, creative idea that hasn't lost its potency. "It's essentially a sampling activation," Kirkham said. "Sampling is a powerful, simple tool to put can-in-hand and brand-in-hand, and get people to try your product in a different way."
At Adobe, the marketing team is first to test many of its own products.
"I am customer zero at the company," said Lara Balazs, Adobe's chief marketing officer. "We are co-creating the products that allow us to go to market. I can give the product people feedback on what works and what doesn't."
Balazs joined Adobe 18 months ago from Intuit, where she also led marketing. She said that being a CMO today means getting ahead of constant changes.
"You're disrupting yourself. You're reinventing yourself so that you're a learner all the time, and not assuming that what you did yesterday is going to get you where you're going to be tomorrow," she said.
DENVER--(BUSINESS WIRE)--Newmont Corporation (NYSE: NEM, ASX: NEM, PNGX: NEM) will release its second quarter 2026 results after North American markets close on Thursday, July 23, 2026. A conference call to discuss the results will be held at 5:30 p.m. Eastern Daylight Time the same day, which is 7:30 a.m. Australian Eastern Standard Time on Friday, July 24, 2026. A replay of the webcast will be available through the Company's website. Webcast Details Title: Newmont's Second Quarter 2026 Result.
Berkshire Hathaway New Q1 BuysBerkshire Hathaway stock may be underperforming major stock market indexes in recent years. Some new stock picks made by Abel in the first quarter could help close the gap.
In the first quarter, Berkshire Hathaway completely exiting more than 15 stock positions was one of the bigger headlines. This included selling some positions that had been owned for years.
Another headline was the new Abel-led company announcing three new stocks bought in the first quarter, which were:
The new purchases surprised some with Buffett often avoiding the airline sector and mostly avoiding technology like Alphabet for years. The conglomerate did own a position in Class A shares (GOOGL) before the first quarter.
With the second quarter over, investors now have one quarter complete since Berkshire’s purchases to track how they are doing. Here’s an updated scorecard.
Greg Abel Stock Buys ScorecardAs of July 1, here are the current profits made from the three stocks that Abel added to Berkshire Hathaway in the first quarter, based on the closing price from March 31, 2026.
Delta Air Lines: $1,074,366,217.44, +40.6% Macy’s: $16,255,199.25, +29.6% Alphabet Class C: $251,466,980.10, +24.5% All three of the new positions are up since the end of the first quarter. In total, the three positions are up around $1.34 billion and have gained 36%.
That’s not a bad return for one quarter for the new stock picks.
Investors will be closely monitoring the conglomerate’s next 13F to see if Abel made more big changes and announces any new stock holdings. Investors will also be watching to see if these new positions are maintained or changed, or if Abel is more okay with taking short-term profits than Buffett was.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
, /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced it will release its second quarter 2026 operating results after the New York Stock Exchange closes on August 5, 2026. Following publication of this earnings release, the company will host its quarterly investor call at 2:00 p.m. PDT.
To access the conference call, dial (833) 816-1264 (United States) or (412) 317-5632 (International). When prompted, please ask for the Realty Income conference call.
A telephone replay of the conference call can also be accessed by calling (855) 669-9658 (United States) or (412) 317-0088 (International) and entering the conference ID 5929348. The telephone replay will be available through August 12, 2026.
A live webcast will be available in listen-only mode by clicking on the webcast link on the company's homepage at www.realtyincome.com. A replay of the conference call webcast will be available approximately one hour after the conclusion of the live broadcast. No access code is required for this replay.
About Realty Income
Realty Income (NYSE: O), an S&P 500 company, is real estate partner to the world's leading companies®. Founded in 1969, we serve our clients as a full-service real estate capital provider. As of March 31, 2026, we have a portfolio of over 15,500 properties in all 50 U.S. states, the U.K., and eight other countries in Europe. We are known as "The Monthly Dividend Company®" and have a mission to invest in people and places to deliver dependable monthly dividends that increase over time. Since our founding, we have declared 672 consecutive monthly dividends and are a member of the S&P 500 Dividend Aristocrats® index for having increased our dividend for over 31 consecutive years. Additional information about the company can be found at www.realtyincome.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this press release, the words "estimate," "anticipate," "assume," "expect," "believe," "intend," "continue," "should," "may," "likely," "plan," "seek," and similar expressions are intended to identify forward-looking statements. Forward-looking statements include discussions of our business strategy, plans, and the intentions of management. Forward-looking statements are subject to risks, uncertainties, and assumptions about us, which may cause our actual future results to differ materially from expected results. Some of the factors that could cause actual results to differ materially are, among others, our continued qualification as a real estate investment trust; general domestic and foreign business, economic, or financial conditions; competition; fluctuating interest and currency rates; inflation and its impact on our clients and us; access to debt and equity capital markets and other sources of funding (including the terms, structure and partners of such funding); volatility and uncertainty in the credit and financial markets; other risks inherent in real estate, private capital, credit and mezzanine investments, and joint ventures or co-investment ventures, including solvency, defaults under leases, bankruptcies, potential liability relating to environmental matters, illiquidity of real estate investments (including rights of first refusal or rights of first offer), and potential damages from natural disasters; impairments in the value of our real estate assets; volatility and changes in domestic and foreign laws and the application, enforcement or interpretation thereof (including with respect to tax laws and rates); property ownership through co-investment ventures, funds, joint ventures, partnerships and other arrangements which, among other things, may transfer or limit our control of the underlying investments; epidemics or pandemics; the loss of key personnel; the threat and outcome of any legal proceedings to which we are a party or which may occur in the future; acts of terrorism and war; the anticipated benefits from mergers, acquisitions, co-investment ventures, funds, joint ventures, partnerships, and other arrangements; and those additional risks and factors discussed in our reports filed with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are not guarantees of future plans and performance and speak only as of the date of this press release. Past operating results and performance are provided for informational purposes and are not a guarantee of future results. There can be no assurance that historical trends will continue. Actual plans and results may differ materially from what is expressed or forecasted in this press release and forecasts made in the forward-looking statements discussed in this press release might not materialize. We do not undertake any obligation to update forward-looking statements or publicly release the results of any forward-looking statements that may be made to reflect events or circumstances after the date these statements were made or to reflect the occurrence of unanticipated events.
, /PRNewswire/ -- Simon®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations, today announced details for its second quarter earnings release and conference call.
Simon's financial and operational results for the quarter ending June 30, 2026, will be released after the market close on August 10, 2026. Simon will host its quarterly earnings conference call and an audio webcast on August 10 from 5:00 p.m. to 6:00 p.m. Eastern Daylight Time.
The live webcast will be available in listen-only mode at investors.simon.com. Interested parties can join the call by dialing:
1-877-423-9813 United States participants 1-201-689-8573 Participants outside the United States The conference ID for the call is "13761320." An audio replay will be available from approximately 9:00 p.m. Eastern Daylight Time on August 10, 2026 until 11:00 p.m. Eastern Daylight Time on August 17, 2026. The replay can be accessed within the United States by dialing 1-844-512-2921. Callers outside the U.S. can access the replay at 1-412-317-6671. The replay passcode is "13761320." The call will also be archived on investors.simon.com for approximately 90 days.
About Simon
Simon® is a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual sales.
RESTON, Va.--(BUSINESS WIRE)--VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that its live earnings teleconference for the second quarter 2026 will take place on Thursday, July 23, 2026, at 4:30 p.m. (EDT). The earnings news release will be distributed to the wire services at approximately 4:05 p.m. (EDT) that day and will also be available directly from the company's website at https://investor.verisign.com.
SummaryPalantir shares have become attractively valued after a sharp decline, despite continued hyper-growth and exceptional profitability.PLTR's AI-driven AIP platform, deep government/military ties, and high net retention (150%) underpin its dominant position and expanding moat.Revenue grew 85% YoY last quarter, with a 57% free cash flow margin; management guides to 72% revenue growth and 59% FCF margin for the year.I recommend initiating a position in PLTR now, despite negative sentiment and technicals, as fundamentals and valuation are compelling for long-term investors. JasonDoiy/iStock Unreleased via Getty Images
The Gold Standard of the Enterprise Software Space is on Sale Now Sometimes it is hard to tell that a sale is underway. Sales do not necessarily mean that something - whether it is an enterprise software
24.1K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of PLTR, SNOW, GOOG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
If you bought GraniteShares 2x Long PLTR Daily ETF (NASDAQ:PTIR) a year ago to double up on Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction), you didn’t. The underlying stock fell about 14.41% over the past year. PTIR fell about 49.16%. The math of “2x” quietly ate the rest.
What You’re Actually Paying The sticker cost is the expense ratio. Neither GraniteShares’ snapshot nor the fund’s NAV history returned a live expense figure in public data feeds, but GraniteShares’ single-stock 2x ETFs generally sit around 1.15% a year. On a $10,000 position would carry roughly $115 per year in fees, or more than a thousand dollars over a decade before compounding. Owning Palantir directly takes that line to zero.
The fee is the least interesting cost here. PTIR delivers 2x the daily return of Palantir, not 2x the annual return. Every trading day, the leverage resets. In choppy markets, that reset compounds against you, a mechanic issuer disclosures acknowledge and industry commentary flags as “volatility decay inherent in leveraged ETFs during choppy markets.”
The Part the Factsheet Doesn’t Highlight Look at year-to-date. PLTR is down 34.36% in 2026. PTIR is down 64.91%. Straight 2x math on the underlying would land nearer to 68%, so a directional slide alone accounts for most of it. Zoom out to one year, though, and the picture ruptures: PLTR down about 14%, PTIR down about 49%. Twice negative-14 is negative-28. The extra roughly 20 percentage points of pain is what daily-reset decay, swap financing, and fees look like when they stack.
The fund is engineered on swaps rather than stock. A peer filing from Direxion Daily PLTR Bull 2X Shares (NASDAQ:PLTU) shows the structure clearly: only 20.97% of net assets in PLTR stock, with roughly 96.6% parked in cash equivalents and the exposure created through derivatives. PTIR uses the same swap-based approach. Those swap contracts carry embedded financing costs tied to short-term rates, so higher rates mean a heavier ongoing drag that never appears on the fee line.
Read: Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
One more quiet cost: the fund does not pay dividends. A direct PLTR holder wouldn’t get much either, but the point is that any income the swap counterparty captures does not flow to you. And a 15-for-1 stock split on July 9, 2025 pitched as making the ETF “more accessible” also made the decay easier to overlook, because per-share losses look smaller after a split.
The Cheaper Mirror The cheapest mirror is Palantir stock itself. Zero expense ratio, no daily reset, no financing spread. You give up the 2x amplification, and on a strong up day you’ll feel that. You also give up the decay. If you insist on 2x, PLTU is the direct competitor: its one-year return was -50.02% versus PTIR’s -49.16%. Basically indistinguishable. The takeaway is that both clones share the same structural bleed.
What This Means for You Over a single directional day or week, PTIR does exactly what it advertises. Seeking Alpha framed the fund plainly: it is “designed for active traders seeking short-term exposure to Palantir (PLTR) around significant events like earnings.” The question worth asking is whether you’re holding a daily trading instrument the way a long-term position is meant to be held. Pull your own cost basis, compare your PTIR return to owning PLTR directly over the same window, and see what the “2x” sticker actually delivered on your money.
If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:
Answer a Few Simple Questions.
Get Matched with Vetted Advisors
Choose Your Fit
Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
Kurv Investment Management's Howard Chan talks about his firm's KMEM ETF and how it offers investors exposure to global AI memory businesses. He then talks about memory's role in AI infrastructure by highlighting chipmakers Micron (MU), Samsung and SK Hynix.
A day after closing out a blockbuster three months on Wall Street, high-flying chip stocks suffered steep declines to open the third quarter.
Memory maker Micron dropped 11%, wiping out $138 billion of market cap. Intel fell 9% and rival chipmaker Advanced Micro Devices dropped 7%.
Those three stocks boomed in the second quarter, adding $2 trillion in combined value, as investors wagered that the artificial intelligence buildout would require an ever-increasing amount of memory as well as more central processors, rather than just the graphics processors made by Nvidia.
The VanEck Semiconductor ETF (SMH), an index that tracks chip stocks, fell more than 5% on Wednesday, a day after closing out the fund's best quarter ever, jumping 71% from the start of April through the end of June.
Other big decliners on Wednesday included semiconductor equipment names Lam Research, KLA Corp. and Applied Materials which all more than doubled in the second quarter. They all fell at least 10%.
One drag on the market was a report that Meta, one of the biggest buyers of AI infrastructure, may be looking to rent out excess computing capacity. That raised fears that AI processing supply may be catching up to demand.
Meta is among a small group of so-called hyperscalers, internet companies that are spending hundreds of billions of dollars a year building out AI data centers. The move was viewed as a positive for Meta, which gained over 9% on Wednesday after a lackluster second quarter.
Analysts at KeyBanc Capital Markets who recommend buying the shares wrote in a note to clients that the move positions Meta "more into the enterprise side of the market, which could provide more immediate" return on investment.
Richard Saperstein, chief investment officer at Treasury Partners, said he would "stick with the hyperscalers" as the market recognizes their strength in the AI trade.
"Earnings are accelerating, yet multiples are compressing," Saperstein said on CNBC's "Closing Bell." "All I can attribute that to hyperscalers have been valued as capital intensive and asset-heavy versus asset-light."
Whatever concerns may be seeping into some of the infrastructure stocks, they have little to do with the most recent financial results. Micron last week reported a more than quadrupling of revenue in the latest quarter, while its gross margin, the profit left after accounting for the cost of goods sold, jumped to 84.9% in the third quarter from 39% a year earlier.
The Amgen logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
SummaryCompaniesJudge says Amgen likely to face significant, irreparable harmEnbrel price was capped at $31,200 annually, list price tops $100,000Colorado declined to commentJuly 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's (AMGN.O), opens new tab blockbuster arthritis drug Enbrel, a first-of-its-kind move by a U.S. state.
In granting a preliminary injunction, Chief Judge Daniel Domenico of the Denver federal court said Amgen would likely face significant and irreparable harm from charging lower prices, adding that it could affect the drugmaker's negotiations for future contracts with wholesalers and distributors.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Domenico said that "as a matter of basic economic logic, Amgen is likely to be significantly harmed by a cap on the price of its product, even if the cap applies unevenly" within the supply chain.
He also said that while Colorado had a legitimate interest in helping patients afford Enbrel, and could try doing so through subsidies or negotiations to lower prices as the federal government has done, "capping the price of a patented drug" was not an option.
In October, the Colorado Prescription Drug Affordability Board capped Enbrel prices at $600 for a 50-milligram weekly dose, or $31,200 per year, effective on January 1, 2027.
The list price of Enbrel exceeds $100,000 per year. Amgen had until July 5 to decide whether to continue selling the drug in Colorado.
Genna Morton, a spokeswoman for Colorado's Division of Insurance, said the agency cannot comment on pending litigation. Amgen and its lawyers did not immediately respond to requests for comment.
The U.S. pays about three times as much as other high-income countries for branded drugs, and the federal government and states have pursued policies to keep prices down.
Enbrel, whose chemical name is etanercept, is used to treat arthritis and plaque psoriasis. It is one of Amgen's biggest drugs, accounting for $2.23 billion of sales in 2025.
The Thousand Oaks, California-based drugmaker said Colorado's cap conflicted with federal patent law, violated its due process rights under the U.S. Constitution and threatened patients' access to needed treatment.
Domenico was appointed to the bench by Donald Trump. The U.S. president has nominated Domenico to join the 10th U.S. Circuit Court of Appeals, whose jurisdiction includes Colorado.
Reporting by Jonathan Stempel in New York; Editing by Mark Porter
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Share postIn BriefExplore Robinhood Chain on Trust Wallet with new support that lets you send, receive, and securely store assets built on the network, all in self-custody.
We're excited to share that Trust Wallet now supports Robinhood Chain. This integration lets you send, receive, manage, and securely Store Tokens issued on Robinhood Chain, directly in your wallet. Network support is live on the Trust Wallet mobile app and browser extension. Adding Robinhood Chain expands Trust Wallet's multi-chain coverage and gives you smoother access to a network built for onchain finance. You stay in full control of your assets the whole time.
About Robinhood Chain Robinhood Chain is a permissionless, Ethereum-compatible Layer-2 network designed for a new generation of onchain finance — a place where tokenized markets, crypto, and real-world assets come together on fast, efficient rails. It reflects Robinhood's wider goal of opening up global financial markets to more people and giving users and developers modern tools to build with. The network makes it possible to move, reach, and manage digital assets from anywhere, with no middlemen and no platform lock-in. To use the new integration, make sure you have the latest version of Trust Wallet.
Download Trust Wallet
How to receive and send Robinhood Chain assets in Trust Wallet Depositing or withdrawing assets on Robinhood Chain is straightforward. Here's how it works.
Receive assets on Robinhood Chain to Trust Wallet Tap the Receive icon from the home screen.
Search for “Robinhood Chain” or click on the Robinhood Chain logo
Select the asset you wish to receive
Copy your deposit address or QR code
Paste this address or scan the QR code into the sending wallet or platform you're transferring from.
Send assets out from Trust Wallet on Robinhood Chain Tap the Send icon from the home screen.
Search for “Robinhood Chain” or click on the Robinhood Chain logo
Select the asset you wish to send
Enter the destination address and amount.
Review the details and select Confirm.
Swap assets on Trust Wallet on Robinhood Chain Tap the Swap icon from the home screen.
Select the token and the chain (Robinhood Chain) that you wish to swap from, and enter the amount.
Select the token and the chain (Robinhood Chain) that you wish to swap to, and enter the amount.
Review the quote and select Confirm.
Stay Tuned for More Updates This integration is only the beginning. Robinhood Chain brings tokenized markets, crypto, and real-world assets together on one open network, and supporting it opens the door to richer onchain experiences for users and developers alike. Stay tuned for exclusive Trust Wallet campaigns with Robinhood!
Update to the latest version of Trust Wallet today to start exploring Robinhood Chain — and stay tuned as we keep building toward a world where you can truly own, access, and move your assets freely, without intermediaries or platform lock-in.
Download Trust Wallet
Simple and convenient to use, seamless to exploreDownload Trust WalletDownload Trust Wallet
New York, New York--(Newsfile Corp. - July 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) between February 11, 2025 and May 7, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
SO WHAT: If you purchased Zillow common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Zillow's agreement with Redfin Corporation was not a "partnership," but rather an acquisition of Redfin's business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, defendants' statements about Zillow's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/303640
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of MercadoLibre, Inc. (“MercadoLibre” or the “Company”) (NASDAQ: MELI) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON MERCADOLIBRE, INC. (MELI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On.
HOUSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its second quarter 2026 financial results after close of market on Wednesday, August 5, 2026, and will hold a conference call to discuss the results on Thursday, August 6, 2026, at 1 p.m. Eastern/12 p.m. Central.
The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10209862/1043a899934.
Second quarter 2026 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed.
About Occidental
Occidental is an international energy company that produces, markets and transports oil and natural gas to maximize value and provide resources fundamental to life. The company leverages its global leadership in carbon management to advance lower-carbon technologies and products. Headquartered in Houston, Occidental primarily operates in the United States, the Middle East and North Africa. To learn more, visit oxy.com.
Choosing between established stability and high-tech growth often defines a portfolio. Whether you prefer the diversified reach of Abbott Laboratories (ABT +1.49%) or the specialized dominance of Intuitive Surgical (ISRG +1.17%), both offer compelling paths.
Abbott operates a broad healthcare empire spanning baby formula to heart valves, providing steady cash flows across market cycles. Intuitive Surgical focuses intensely on robotic-assisted surgery, benefiting from an ecosystem that generates significant recurring revenue. This comparison involves weighing broad diversification against narrow, high-margin specialization in the healthcare sector.
The case for Abbott LaboratoriesAbbott Laboratories operates across four primary segments, including medical devices, diagnostics, nutrition, and established pharmaceuticals. It sells these products globally to a diverse customer base of wholesalers, hospitals, clinics, and government agencies. In March 2026, the company completed its acquisition of Exact Sciences Corporation, a move designed to expand its presence in the cancer diagnostics market.
Financial results show the scale of these operations. In FY 2025, revenue reached nearly $44.3 billion, up roughly 5.7% from the previous year. Net income for the same period was close to $6.5 billion, while the company maintained a net margin of approximately 14.7%.
As an established player among medical device stocks, Abbott maintains a sturdy balance sheet. According to its December 2025 balance sheet, the debt-to-equity ratio was roughly 0.3x, which measures total debt relative to shareholders’ equity. The current ratio, which gauges the ability to cover short-term obligations with short-term assets, stood at approximately 1.6x, and the company generated roughly $7.4 billion in free cash flow.
The case for Intuitive SurgicalIntuitive Surgical provides a robotic-assisted surgical ecosystem, primarily through its da Vinci and Ion platforms. The company generates revenue by selling these systems to hospitals and then providing the ongoing instruments, accessories, and services required for procedures. In early 2026, the company strengthened its international footprint by bringing several European distribution businesses in-house through strategic acquisitions.
Growth has remained robust for the robotic surgery pioneer. In FY 2025, revenue reached close to $10.1 billion, which was a significant increase of approximately 20.5% over the prior year. Net income for the period was roughly $2.9 billion, supported by a healthy net margin of nearly 28.4%.
Financial health remains a core strength for the company. As of its December 2025 balance sheet, the debt-to-equity ratio was 0.0x, indicating the company has virtually no debt relative to its equity. The current ratio was approximately 4.9x, and free cash flow reached nearly $2.5 billion. Note that stock-based compensation accounted for roughly 26.0% of operating cash flow, thereby inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.
Risk profile comparisonAbbott Laboratories faces several headwinds, including product liability and legal exposure related to its infant formula and spinal cord stimulators. The $20 billion in debt incurred to acquire Exact Sciences has also significantly increased its total indebtedness, reducing financial flexibility and increasing its sensitivity to interest rate changes. Furthermore, the company remains under intense regulatory scrutiny from the FDA regarding its manufacturing and marketing claims.
Intuitive Surgical must navigate complex global regulations and potential delays in regulatory reviews for its new products. The company is also vulnerable to cybersecurity threats that could compromise its connected surgical systems or patient data privacy. Additionally, the robotic-assisted surgery market is increasingly competitive, and consolidation among healthcare providers could lead to downward pressure on system pricing and profit margins.
Valuation comparisonAbbott Laboratories offers a significantly lower entry point based on sales and future earnings estimates compared to the premium valuation assigned to Intuitive Surgical.
MetricAbbott LaboratoriesIntuitive SurgicalSector BenchmarkForward P/E17.1x38.7x24.8xP/S ratio3.7x14.2xn/aSector benchmark uses the SPDR XLV sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Both of these companies appear to be good choices for a long-term investor’s portfolio. Both are leaders in their medical technology niches, and both have strong performance and growth potential. And although one may have slightly higher growth potential than the other, there are two other key differences driving investors’ choice.
Intuitive Surgical is the maker of the da Vinci robotic surgery platform. It’s installed in over 7,500 hospitals worldwide, and this technology has treated more than 20 million patients. It trades at a premium valuation relative to the broader medical technology and healthcare sectors, largely driven by its “razor-and-blades” model of recurring revenue from the sale of its instruments and accessories. It also benefits from high switching costs. However, it does not pay a dividend.
Abbott Laboratories is diversified. Its operations include pharmaceuticals, diagnostics, nutritional products, and medical devices. Its FreeStyle Libre continuous glucose monitoring system has driven growth in recent years, and its March 2026 acquisition of Exact Sciences represents another major expansion into cancer diagnosis. Abbott has a long track record of dividend increases, demonstrating it has the cash flow and stability to support them.
Investors seeking higher growth potential may prefer Intuitive Surgical. But for those looking for steady growth and dividend income, Abbott Laboratories is the stock I would choose.
Key Takeaways BUD's digital platforms, including BEES and Ze Delivery, are expanding customer reach and engagement.BUD's B2B digital platforms contributed about 72% of revenues in Q1 2026, supporting growth.BUD's premium beer portfolio posted 11% revenue rise in Q1, led by Corona, Stella Artois and Michelob Ultra. In a fast-evolving beverage environment, Anheuser-Busch InBev SA/NV (BUD - Free Report) , also known as AB InBev, emerges as a distinctively positioned contender, strengthening its foothold in the global alcoholic beverage market. As a global brewing titan, AB InBev continues to dominate the industry through its expansive sourcing and distribution network, strategic focus on premiumization, accelerating digital transformation and consistent investment in brand equity.
AB InBev continues to enhance its digital capabilities to deepen customer engagement, with a strong emphasis on digitizing and monetizing its ecosystem. The company is expanding its tech-driven platforms, particularly its B2B and e-commerce channels like BEES and Zé Delivery. BEES delivered a strong performance, generating $14.6 billion in gross merchandise value (GMV), up 15% year over year. Digital DTC megabrands, Zé Delivery, TaDa Delivery and PerfectDraft, served 12 million active consumers, generating $139 million in revenues in first-quarter 2026, with third-party sales through DTC marketplace reaching $41 million of GMV.
The company’s digital transformation initiatives have been on track, with B2B digital platforms contributing about 72% to its revenues in first-quarter 2026. In DTC, BUD’s digital platforms enable a one-to-one connection with consumers, hence developing new occasions. Digital momentum is likely to continue and bolster the company’s overall revenues.
Premiumization remains a key lever for AB InBev as consumers trade up within beer and it concentrates investment behind its megabrands. In first-quarter 2026, the above core beer portfolio delivered an 11% revenue increase, driven by Corona, Stella Artois and Michelob Ultra. Corona also increased volumes by double digits in 32 markets in the reported quarter, supporting a sustained premium mix contribution. The company has highlighted that its disciplined revenue management and strong portfolio of higher-priced brands support revenue per hl and margin resiliency over time. As AB InBev continues to activate global platforms such as major sports moments and scale premium brands across more markets, it has an opportunity to protect pricing power through the cycle.
BUD’s Price Performance, Valuation and EstimatesAB InBev shares have gained 27.5% in the past six months compared with the industry’s 14.9% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BUD trades at a forward price-to-earnings ratio of 17.99X compared with the industry’s average of 15.38X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BUD’s 2026 and 2027 earnings per share (EPS) indicates year-over-year growth of 16.1% and 11.5%, respectively. The company’s EPS estimates for 2026 have moved upward in the past seven days while that of 2027 have moved downward.
Image Source: Zacks Investment Research
AB InBev currently carries a Zacks Rank #3 (Hold).
Stocks to Consider in the Consumer Staples SpaceThe Chefs' Warehouse, Inc. (CHEF - Free Report) , which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Chefs' Warehouse current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank #2 (Buy).
The consensus estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED delivered an average earnings surprise of 65.5% in the last reported quarter.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number.
Characteristics and Risks of Standardized Options: https://bit.ly/2v9tH6D. ServiceNow (NOW) has taken a beating ever since the SaaS-pocalypse after investors expressed AI disruption fears.
, /PRNewswire/ -- STAG Industrial, Inc. (the "Company") (NYSE: STAG) today announced that the Company will release its second quarter 2026 operating and financial results after market close on Tuesday, July 28, 2026. The Company will host its quarterly earnings conference call on Wednesday, July 29, 2026, at 10:00 a.m. Eastern Time.
The call can be accessed live over the phone toll-free by dialing (877) 407-4018, or for international callers, (201) 689-8471. A replay will be available shortly after the call and can be accessed by dialing (844) 512-2921, or for international callers, (412) 317-6671. The passcode for the replay is 13761520.
Interested parties also may listen to a simultaneous webcast of the conference call by visiting the Investor Relations section of the Company's website at www.stagindustrial.com, or by clicking on the following link:
http://ir.stagindustrial.com/CorporateProfile
About STAG Industrial, Inc.
STAG Industrial, Inc. is a real estate investment trust focused on the acquisition, development, ownership, and operation of industrial properties throughout the United States. As of March 31, 2026, the Company's portfolio consists of 601 buildings in 41 states with approximately 120.3 million rentable square feet.
For additional information, please visit the Company's website at www.stagindustrial.com.
Forward-Looking Statements
This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, are generally identifiable by use of the words "believe," "will," "expect," "intend," "anticipate," "estimate," "should," "project" or similar expressions. You should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control and which could materially affect actual results, performances or achievements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the risk factors discussed in the Company's annual report on Form 10-K for the year ended December 31, 2025, as updated by the Company's quarterly reports on Form 10-Q. Accordingly, there is no assurance that the Company's expectations will be realized. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in the Company's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statement is based.
Plug Power stock is under selling pressure. Why are PLUG shares declining? What Is Driving Plug Power’s Growth in Denmark?The recent spark for PLUG has been its progress in Denmark, where the company said it completed installation, commissioning, site acceptance testing and handover of a 5 MW GenEco PEM electrolyzer system at the Måde Power-to-X facility in Esbjerg, moving the site into active hydrogen production.
At full capacity, Plug expects about 550 metric tons of green hydrogen per year (roughly 1,500 truckloads), with output certified as Renewable Fuel of Non-Biological Origin under the ISCC scheme.
Plug has been leaning hard into "repeatable execution," highlighting a fully containerized design intended to reduce on-site complexity and accelerate production readiness, a message CEO José Luis Crespo has tied to more disciplined growth.
Plug Power Stock: Key Levels To WatchFrom a longer-term trend view, the stock is trying to hold its base above the 200-day moving average ($2.62) but is still trading below the faster trend gauges—about 6.9% under the 20-day SMA ($2.86) and 17.7% under the 50-day SMA ($3.24). That setup often means rallies can run into overhead supply near those moving averages unless buyers can string together a few stronger closes.
Momentum is best framed by MACD right now: it’s below its signal line and the histogram is negative, which points to upside pressure fading versus the prior upswing unless it can reclaim that baseline. In plain terms, MACD compares shorter- and longer-term trend momentum, and being below the signal line usually means the push higher is losing steam.
The crossover picture stays split, with the 20-day SMA below the 50-day SMA (bearish near-term structure) but the 50-day SMA still above the 200-day SMA, keeping the September 2025 golden cross intact. Zooming out, the stock remains in a wide 52-week range between $1.24 and $4.58, with April’s swing low and June’s swing high still framing the current consolidation.
Key Resistance: $2.86 — the 20-day SMA is nearby and can act as the first "sell zone" if rebounds fade Key Support: $2.62 — the 200-day SMA is close and has been a key line-in-the-sand for the longer-term trend What Is Plug Power’s Green Hydrogen Strategy?Plug Power is building an end-to-end green hydrogen ecosystem, spanning production, storage, and delivery through to energy generation. The company’s strategy is to build and operate green hydrogen highways across North America and Europe.
That’s why the Denmark handover is a meaningful data point: it’s a real operating proof that Plug can deliver electrolyzer projects into active production, not just announce them. Management has also been emphasizing a more repeatable, containerized design approach aimed at reducing on-site complexity and speeding time-to-production, which is central to rebuilding confidence after a volatile 12 months.
Plug Power Stock Price Movement on WednesdayPLUG Stock Price Activity: Plug Power shares were down 1.85% at $2.66 at the time of publication on Wednesday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
July 01, 2026 16:05 ET | Source: Devon Energy Corporation
OKLAHOMA CITY, July 01, 2026 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today announced it will report second-quarter 2026 results on Tuesday, August 4, after the close of U.S. financial markets. The earnings release and presentation for the second-quarter 2026 results will be available on the company’s website at www.devonenergy.com.
On Wednesday, August 5, the company will hold a conference call at 10 a.m. CDT (11 a.m. EDT), which will consist primarily of answers to questions from analysts and investors. A webcast link to the conference call will be provided on Devon’s website at www.devonenergy.com. A replay will be available on the website following the call.
ABOUT DEVON ENERGY
Devon Energy is a leading oil and gas producer in the U.S. with a premier multi-basin portfolio anchored by our world-class position in the Delaware Basin, as well as high quality assets in the Anadarko Basin, Eagle Ford Shale, Marcellus Shale, Powder River Basin and Williston Basin. Devon’s disciplined capital allocation model is designed to achieve strong returns, generate resilient free cash flow and return capital to shareholders, while focusing on safe and sustainable operations. For more information, please visit www.devonenergy.com.
SAN MATEO, Calif.--(BUSINESS WIRE)--On Friday, July 31st at approximately 8:30 a.m. Eastern Time, Franklin Resources, Inc. (the “Company”) [NYSE:BEN] will release its third quarter operating results. A written commentary on the results will also be available via investors.franklinresources.com at approximately 8:30 a.m. Eastern Time.
In addition, Jenny Johnson, CEO; Matthew Nicholls, Co-President, CFO and COO; and Daniel Gamba, Co-President and Chief Commercial Officer, will lead a live teleconference at 10:00 a.m. Eastern Time to answer questions.
Access to the teleconference will be available via investors.franklinresources.com or by dialing (+1) 877-407-0989 in North America or (+1) 201-389-0921 in other locations. A replay of the teleconference can also be accessed by calling (+1) 877-660-6853 in North America or (+1) 201-612-7415 in other locations using access code 13761569 after 2:00 p.m. Eastern Time on July 31, 2026 through August 7, 2026, or via investors.franklinresources.com. Analysts and investors are encouraged to review the Company's recent filings with the U.S. Securities and Exchange Commission and to contact Investor Relations at [email protected] before the live teleconference for any clarifications or questions related to the earnings release or written commentary.
About Franklin Templeton
Franklin Templeton is a trusted investment partner, delivering tailored solutions that align with clients’ strategic goals. With deep portfolio management expertise across public and private markets, we combine investment excellence with cutting-edge technology. Since our founding in 1947, we have empowered clients through strategic partnership, forward-looking insights, and continuous innovation – providing the tools and resources to navigate change and capture opportunity.
With $1.78 trillion in assets under management as of May 31, 2026, Franklin Templeton operates globally in more than 35 countries.
To learn more, visit franklintempleton.com and follow us on LinkedIn.
, /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the company completed the sale and transfer of the manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities. The transaction closed as planned on July 1, 2026.
West will continue to develop and manufacture all other versions of SmartDose, including SmartDose® 10mL On-Body Delivery System, adaptive technology for larger volumes.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites, including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”), of the important July 28, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (2) the foregoing was likely to, and did, have a material negative impact on Lucid’s business and financial results; (3) accordingly, the defendants had overstated the purported enhancements to Lucid’s manufacturing and delivery capabilities and overall operations; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
UPST weekly chart shows long-term trend reversal from bottom in process. Source: TradingView Technical Structure Favors the Bulls The subsequent formation of a symmetrical triangle consolidation pattern further strengthened the bullish technical outlook. All major moving averages were reclaimed, along with the downtrend line. Most recently, the pullback confirmed support near the downtrend line and the 20-day and 50-day moving averages. The two averages had converged near one another, reflecting price compression and the potential for an expansion in bullish momentum.
Support Holds the Key to Higher Targets Since the initial triangle breakout signal occurred on Monday above $34.02, traders will be watching for the first pullback and a subsequent resumption of the trend. Key support is near the breakout zone and a decline to that area would be normal. However, if support holds above that level, followed by renewed buying pressure, it will indicate stronger demand. Conversely, a failure to hold support and a move back into the triangle would signal weakness.
Initial upside targets begin with the 200-day moving average, currently near $38.92 and falling. Above that, a prior swing high at $41.64 from February marks the next resistance area, while the 78.6% Fibonacci retracement of the prior decline at $46.08 identifies the next upside target zone. Whether the breakout develops into a sustained advance will likely depend on how the stock behaves during its first meaningful pullback. Holding above the breakout zone would reinforce the bullish reversal signaled at the start of the week and increase the probability that a new intermediate-term uptrend is underway.
Company to Appoint Mutually Agreed Upon Independent Director; Forms Stockholder Engagement and Clinical and Regulatory Affairs Committees
Stockholder Group Withdraws Director Nominations
SOUTH SAN FRANCISCO, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, today announced a resolution to the proxy contest in connection with the Company’s 2026 Annual Meeting of Stockholders, reflecting a commitment to value creation, strong corporate governance and constructive engagement with stockholders.
Vaxart will initiate a search for an additional independent director to be conducted within 90 days of the conclusion of the 2026 Annual Meeting. Pursuant to a cooperation agreement between the Company and stockholders Daniel P. Houle, Mark Silverberg, DDS, MD, Matthew M. Wallace, MD, Patrice Raffy, Marc Eustace Pereira and Q3 Nominees Pty Ltd. (the “Stockholder Group”), the Company will work with the Stockholder Group to identify a mutually agreeable candidate to be appointed to the Board. The Stockholder Group has also agreed under the cooperation agreement to withdraw the director nominations of Mr. Houle, Dr. Silverberg and Dr. Wallace in connection with the 2026 Annual Meeting.
The cooperation agreement additionally provides for the formation of a Stockholder Engagement Committee and a Clinical and Regulatory Affairs Committee, Board committee refreshment, including the selection of new chairs for the Nominating and Governance and Compensation Committees, the adoption of director stock ownership and resignation policies, as well as certain customary standstill, voting, engagement and other provisions.
“Vaxart is approaching a series of important value-inflection milestones, and these actions enable the Company to move forward with a unified focus on executing its strategy,” said W. Mark Watson, Lead Independent Director of Vaxart’s Board. “We appreciate the constructive dialogue with the Stockholder Group toward our shared goal of creating value and are pleased to resolve our proxy contest so we can dedicate our full resources and attention to advancing our pipeline with stockholder interests in mind. We believe these governance enhancements will reinforce the continuity of experienced oversight needed as Vaxart enters its next phase of growth.”
The Stockholder Group commented, “We are pleased to have reached an agreement that enhances Vaxart’s corporate governance and engagement with stockholders. We have long believed in the potential of Vaxart’s science and differentiated oral vaccine platform. The actions announced today strengthen Board oversight and accountability and give us confidence that Vaxart is positioned to unlock significant value for stockholders.”
The cooperation agreement will be filed on a Form 8-K with the U.S. Securities and Exchange Commission.
Goodwin Procter LLP and Thompson Hine LLP are serving as legal advisors and Joele Frank, Wilkinson Brimmer Katcher is serving as strategic communications advisor to Vaxart. Olshan Frome Wolosky LLP is serving as legal advisor to the Stockholder Group.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the Company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Cautionary Language Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” provisions created by those sections, that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Vaxart’s strategy, prospects, plans and objectives, results from preclinical and clinical trials, commercialization agreements and licenses, and beliefs and expectations of management are forward-looking statements. These forward-looking statements may be accompanied by such words as “should,” “believe,” “could,” “potential,” “will,” “expected,” “anticipate,” “plan,” “target,” “seek,” “intend,” “may,” “predict,” “project,” “would,” and other words and terms of similar meaning. Actual results or events could differ materially from the plans, intentions, expectations, and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Vaxart makes, including uncertainties inherent in research and development and other risks and uncertainties described in the “Risk Factors” sections of Vaxart’s most recent Annual Report on Form 10-K, as amended, and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission. Vaxart undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.
Important Additional Information and Where to Find It
Vaxart has filed a definitive proxy statement and form of white proxy card with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies for the 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Stockholders are able to obtain the Company’s proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC’s website at www.sec.gov. Copies are also available at no charge at the Company’s website at https://investors.vaxart.com/financials-filings/sec-filings.
